tiprankstipranks
Advertisement
Advertisement

NRSN Stock Latest News

NeuroSense initiated with a Buy at H.C. Wainwright
The FlyNeuroSense initiated with a Buy at H.C. Wainwright
4d ago
NRSN
NeuroSense Rewrites the Standard ALS Playbook With a Faster, Leaner Path to Potential Approval
PremiumTipRanks Newswire
NeuroSense Rewrites the Standard ALS Playbook With a Faster, Leaner Path to Potential Approval
7d ago
CLNN
NRSN
NeuroSense announces redesigned development plan for PrimeC
PremiumThe Fly
NeuroSense announces redesigned development plan for PrimeC
7d ago
NRSN
NeuroSense Shareholders Approve Flexible Reverse Share Split Authorization
PremiumCompany Announcements
NeuroSense Shareholders Approve Flexible Reverse Share Split Authorization
11d ago
6K
NRSN
NeuroSense CEO Details Phase 3 ALS Trial Plans, Canada Filing and Nasdaq Compliance Efforts
PremiumCompany Announcements
NeuroSense CEO Details Phase 3 ALS Trial Plans, Canada Filing and Nasdaq Compliance Efforts
25d ago
6K
NRSN
NeuroSense Advances PrimeC Toward December 2026 Health Canada Filing After Completing Pre-NDS Process
PremiumCompany AnnouncementsNeuroSense Advances PrimeC Toward December 2026 Health Canada Filing After Completing Pre-NDS Process
1M ago
6K
NRSN
NeuroSense sees December 2026 as filing date for NDS for PrimeC
Premium
The Fly
NeuroSense sees December 2026 as filing date for NDS for PrimeC
1M ago
NRSN
NeuroSense Updates Capital on Demand Program After New F-3 Becomes Effective
Premium
Company Announcements
NeuroSense Updates Capital on Demand Program After New F-3 Becomes Effective
1M ago
6K
NRSN
NeuroSense Therapeutics Calls August 26 Shareholder Vote on Wide-Range Reverse Share Split
PremiumCompany Announcements
NeuroSense Therapeutics Calls August 26 Shareholder Vote on Wide-Range Reverse Share Split
1M ago
6K
NRSN
NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS
PremiumCompany Announcements
NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS
2M ago
6K
NRSN
NeuroSense to file NDS to Health Canada for PrimeC for treatment of ALS
PremiumThe Fly
NeuroSense to file NDS to Health Canada for PrimeC for treatment of ALS
2M ago
NRSN
NeuroSense Hits Key TDP-43 Endpoint in Phase 2b ALS Trial, Advances Toward Phase 3
PremiumCompany Announcements
NeuroSense Hits Key TDP-43 Endpoint in Phase 2b ALS Trial, Advances Toward Phase 3
2M ago
6K
NRSN
NeuroSense says Phase 2b PARADIGM study of PrimeC in ALS met endpoint
PremiumThe FlyNeuroSense says Phase 2b PARADIGM study of PrimeC in ALS met endpoint
2M ago
NRSN
NeuroSense Posts Positive Phase 2 Biomarker Signals for PrimeC in Alzheimer’s Trial
Premium
Company Announcements
NeuroSense Posts Positive Phase 2 Biomarker Signals for PrimeC in Alzheimer’s Trial
2M ago
6K
NRSN
NeuroSense Secures South Korean Patent for ALS Drug Candidate PrimeC
Premium
Company Announcements
NeuroSense Secures South Korean Patent for ALS Drug Candidate PrimeC
3M ago
6K
NRSN
NeuroSense granted South Korean patent covering PrimeC composition for ALS
PremiumThe Fly
NeuroSense granted South Korean patent covering PrimeC composition for ALS
3M ago
NRSN
NeuroSense Therapeutics Wins Key Japanese Patent for ALS Drug PrimeC
PremiumCompany Announcements
NeuroSense Therapeutics Wins Key Japanese Patent for ALS Drug PrimeC
3M ago
6K
NRSN
NeuroSense granted Japanese patent for PrimeC novel composition in ALS
PremiumThe Fly
NeuroSense granted Japanese patent for PrimeC novel composition in ALS
3M ago
NRSN
NeuroSense Therapeutics Advances Canadian Regulatory Talks on ALS Drug PrimeC
PremiumCompany Announcements
NeuroSense Therapeutics Advances Canadian Regulatory Talks on ALS Drug PrimeC
3M ago
6K
NRSN
NeuroSense Secures Insider-Led $600,000 PIPE at Premium Share Price
PremiumCompany AnnouncementsNeuroSense Secures Insider-Led $600,000 PIPE at Premium Share Price
4M ago
6K
NRSN
NeuroSense announces departure of Chief Medical Officer
Premium
The Fly
NeuroSense announces departure of Chief Medical Officer
4M ago
NRSN
NeuroSense Therapeutics Transitions Chief Medical Officer to Advisory Role Ahead of Key PrimeC Milestones
Premium
Company Announcements
NeuroSense Therapeutics Transitions Chief Medical Officer to Advisory Role Ahead of Key PrimeC Milestones
5M ago
6K
NRSN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >